ZIMBERELIMAB

UNII: ZBL7O904IL
Preferred Substance Name: ZIMBERELIMAB

2259860-24-5
AB122
AB-122
ANTI-PD-1 MONOCLONAL ANTIBODY GLS-010
GLS-010
IMMUNOGLOBULIN G4(231-PROLINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL AB122 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AB122 .LAMBDA.-CHAIN, DIMER
WBP3055
WBP-3055
ZIMBERELIMAB [INN]
ZIMBERELIMAB [USAN]
ZIMBERELIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

ZIMBERELIMAB

Synonyms and Mappings

Resources

Note